1 year return (CAGR)
-17.94%
Lyell Immunopharma Inc Exchange (NASDAQ, USD)
LYEL
11.15
-0.14 (-1.24%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-35.42%
5 year return (CAGR)
-49.89%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
264.04M
Price/Sales
9779.37
Ent value
268.40M
Price/Book
1.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-4.69%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 10.91 |
| Daily high | 10.98 |
| Daily low | 10.46 |
| Daily Volume | 155K |
| All-time high | 38.60 |
| 1y analyst estimate | 37.88 |
| Beta | -0.07 |
| EPS (TTM) | -10.63 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LYEL | S&P500 | |
| Current price drop from All-time high | -71.11% | -0.58% |
| Highest price drop | -98.52% | -56.47% |
| Date of highest drop | 30 May 2025 | 9 Mar 2009 |
| Avg drop from high | -63.52% | -10.68% |
| Avg time to new high | 66 days | 12 days |
| Max time to new high | 774 days | 1805 days |
News
